Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions. (Q49972906)
Jump to navigation
Jump to search
scientific article published in December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions. |
scientific article published in December 2016 |
Statements
1 reference
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions. (English)
1 reference
Donna Neuberg
1 reference
Jacalyn Rosenblatt
1 reference
Richard M Stone
1 reference
Lynne Uhl
1 reference
Robin Joyce
1 reference
James D Levine
1 reference
Jon Arnason
1 reference
Malgorzata McMasters
1 reference
Katarina Luptakova
1 reference
Salvia Jain
1 reference
Jeffrey I Zwicker
1 reference
Ayad Hamdan
1 reference
Vassiliki Boussiotis
1 reference
David P Steensma
1 reference
Daniel J DeAngelo
1 reference
Ilene Galinsky
1 reference
Poorvi Somaiya Dutt
1 reference
Emma Logan
1 reference
Mary Paty Bryant
1 reference
Dina Stroopinsky
1 reference
Lillian Werner
1 reference
Kristen Palmer
1 reference
Max Coll
1 reference
Abigail Washington
1 reference
Leandra Cole
1 reference
Donald Kufe
1 reference
David Avigan
1 reference
1 December 2016
1 reference
1 reference
8
1 reference
368ra171
1 reference
368
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference